Spironolactone and XPB: An Old Drug with a New Molecular Target
Sign Up to like & getrecommendations! Published in 2020 at "Biomolecules"
DOI: 10.3390/biom10050756
Abstract: Spironolactone (SP) is commonly used for the treatment of heart failure, hypertension, and complications of cirrhosis by antagonizing the mineralocorticoid receptor. However, SP also antagonizes the androgen receptor, and thus SP has also been shown… read more here.
Keywords: xpb; xpb old; old drug; drug new ... See more keywords